Products Categories
CAS No.: | 77-21-4 |
---|---|
Name: | DL-Glutethimide |
Article Data: | 17 |
Molecular Structure: | |
Formula: | C13H15 N O2 |
Molecular Weight: | 217.268 |
Synonyms: | Glutarimide,2-ethyl-2-phenyl- (7CI,8CI); (?à)-2-Ethyl-2-phenylglutarimide; (?à)-3-Ethyl-3-phenyl-2,6-piperidinedione; (?à)-Glutethimide;2-Ethyl-2-phenylglutarimide; 2-Phenyl-2-ethylglutaric acid imide;3-Ethyl-3-phenyl-2,6-diketopiperidine; 3-Ethyl-3-phenyl-2,6-dioxopiperidine;3-Ethyl-3-phenyl-2,6-piperidinedione; 3-Ethyl-3-phenylglutarimide;3-Phenyl-3-ethyl-2,6-diketopiperidine; 3-Phenyl-3-ethyl-2,6-dioxopiperidine;Doriden; Doriden-Sed; Elrodorm; Glimid; Glutethimid; Glutethimide; Glutetimid;NSC 95239; Noxiron; Noxyron; Rigenox; Sarodormin; a-Ethyl-a-phenylglutarimide; a-Phenyl-a-ethylglutaricacid imide; a-Phenyl-a-ethylglutarimide |
EINECS: | 201-012-0 |
Density: | 1.11 g/cm3 |
Melting Point: | 84°C |
Boiling Point: | 393.5 °C at 760 mmHg |
Flash Point: | 161.8 °C |
Solubility: | 0.95g/L(27 oC) |
Appearance: | White crystalline powder. |
Hazard Symbols: | Xn,T,F |
Risk Codes: | 22-39/23/24/25-23/24/25-11 |
Safety: | Poison by ingestion and intraperitoneal routes. Human systemic effects by ingestion: pupillary dilation, ataxia, somnolence, coma, and blood pressure depression. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx. Caution: May be habit forming. This is a controlled substance (depressant) listed in the U.S. Code of Federal Regulations, Title 21 Part 1308.13 (1985). |
PSA: | 46.17000 |
LogP: | 2.09980 |
1. | orl-chd TDLo:25 mg/kg:CNS | AJDCAI American Journal of Diseases of Children. 130 (1976),507. | ||
2. | orl-hmn TDLo:171 mg/kg | JAMAAP JAMA, Journal of the American Medical Association. 214 (1970),1704. | ||
3. | unr-man LDLo:147 mg/kg | 85DCAI Poisoning; Toxicology, Symptoms, Treatments. 2 (1970),73. | ||
4. | orl-rat LD50:600 mg/kg | 27ZQAG Psychotropic Drugs and Related Compounds E. Usdin andD.H. Efron,2nd ed.,Washington, DC.: 1972,233. | ||
5. | orl-mus LD50:360 mg/kg | 27ZQAG Psychotropic Drugs and Related Compounds E. Usdin andD.H. Efron,2nd ed.,Washington, DC.: 1972,233. | ||
6. | ipr-mus LD50:208 mg/kg | APPHAX Acta Poloniae Pharmaceutica. 32 (1975),243. | ||
7. | orl-dog LD50:500 mg/kg | SMWOAS Schweizerische Medizinische Wochenschrift. 85 (1955),305. | ||
8. | orl-mky LDLo:300 mg/kg | TXAPA9 Toxicology and Applied Pharmacology. 29 (1974),75. |
Legal status
Glutethimide(77-21-4) is a Schedule II drug under the Convention on Psychotropic Substances. It was originally a Schedule III drug in the United States under the Controlled Substances Act, but in 1991 it was upgraded to Schedule II, more than a decade after recreational abusers discovered that combining the drug with codeine produced a euphoria which closely resembles that obtained from heroin.
A question has appeared on the DABT examination on Glutethimide(77-21-4).